消化性潰瘍の世界市場レポート 2025年

消化性潰瘍の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR3.7％で49億1,000万米ドルに成長します。予測期間の成長は、新たな治療法や治療方法、高齢者人口の増加、精密医療の統合、予防対策と健康増進、継続的な調査と臨床試験に起因しています。予測期間の主な動向には、デジタルヘルスソリューション、治療方法の進歩、ヘリコバクター・ピロリ感染の有病率の増加、画像診断技術の統合、併用療法の増加などがあります。

肥満の罹患率の上昇が、今後の消化性潰瘍市場の成長を牽引すると予測されます。肥満症は、体脂肪の過剰な蓄積によって特徴づけられる病状であり、一般的には体格指数（BMI）が30以上であると定義されます。肥満症は、食生活の乱れや運動不足など、遺伝的、環境的、生活習慣的要因の組み合わせによって発症します。肥満は胃酸の過剰分泌を招き、胃粘膜の保護機能を低下させ、消化性潰瘍の開発を助長します。さらに、過剰な体重は腸内の炎症を増加させ、消化性潰瘍の発生をさらに促進させるようです。例えば、2024年9月、米国を拠点とする公衆衛生機関である疾病対策予防センターは、2021年8月から2023年8月の間に成人の肥満の有病率は40.3％であり、男性では39.2％、女性では41.3％であったと報告しています。このように、肥満の増加が消化性潰瘍市場の拡大を牽引しています。

喫煙率の上昇は、消化性潰瘍市場の成長を当面促進すると予想されます。喫煙は、タバコやマリファナなどの植物性製品の燃焼による蒸気の吸入であり、消化性潰瘍疾患の原因として確立されています。喫煙は胃や十二指腸の粘膜を傷つけ、胃への血液供給を減らし、胃酸の分泌を増加させ、消化性潰瘍の発生率を高める。例えば、2023年6月にビクトリア州が発表したデータでは、14～17歳の現在の喫煙率は4年間で3倍に増加し、2022年には6.7％に達することが明らかになりました。その結果、喫煙率の上昇は消化性潰瘍市場の促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界消化性潰瘍PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の消化性潰瘍市場：成長率分析
• 世界の消化性潰瘍市場の実績：規模と成長, 2019-2024
• 世界の消化性潰瘍市場の予測：規模と成長, 2024-2029, 2034F
• 世界消化性潰瘍総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の消化性潰瘍市場：疾患適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 胃炎
• 胃潰瘍
• 十二指腸潰瘍
• 胃食道逆流症（GERD）
• 世界の消化性潰瘍市場薬の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プロトンポンプ阻害剤（PPI）
• H2拮抗薬
• 抗生物質
• その他の薬物
• 世界の消化性潰瘍市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 個人クリニック
• ドラッグストア
• 小売薬局
• eコマース
• 世界の消化性潰瘍市場、胃炎の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性胃炎
• 慢性胃炎
• 世界の消化性潰瘍市場胃潰瘍の種類別の分類、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性胃潰瘍
• 慢性胃潰瘍
• 世界の消化性潰瘍市場十二指腸潰瘍の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性十二指腸潰瘍
• 慢性十二指腸潰瘍
• 世界の消化性潰瘍市場胃食道逆流症（GERD）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非びらん性胃食道逆流症
• びらん性胃食道逆流症

第7章 地域別・国別分析

• 世界の消化性潰瘍市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の消化性潰瘍市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 消化性潰瘍市場：競合情勢
• 消化性潰瘍市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• CSL Limited
• Boehringer Ingelheim International GmbH
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Company
• Dr. Reddy's Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 消化性潰瘍市場2029：新たな機会を提供する国
• 消化性潰瘍市場2029：新たな機会を提供するセグメント
• 消化性潰瘍市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

An open sore or raw area in the stomach lining or intestine is known as a peptic ulcer. It is primarily a result of the erosion of the protective lining of the stomach or the upper part of the small intestine, known as the duodenum. Common symptoms of peptic ulcers include upper abdominal pain or discomfort and symptoms of acid reflux, such as heartburn, sometimes accompanied by nausea.

The primary disease indications consist of gastritis, gastric ulcers, duodenal ulcers, and gastroesophageal reflux disease (GERD). Gastritis is a medical condition characterized by inflammation, irritation, or erosion of the stomach lining. The typical approach to treating gastritis involves medications such as proton pump inhibitors and lifestyle adjustments. The drugs utilized include proton pump inhibitors (PPI), H2 antagonists, antibiotics, and other pharmaceuticals, which are distributed through various channels such as hospital pharmacies, private clinics, drug stores, retail pharmacies, and e-commerce.

The peptic ulcer market research report is one of a series of new reports from The Business Research Company that provides peptic ulcer market statistics, including peptic ulcer industry global market size, regional shares, competitors with a peptic ulcer market share, detailed peptic ulcer market segments, market trends and opportunities, and any further data you may need to thrive in the peptic ulcer industry. This peptic ulcer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peptic ulcer market size has grown steadily in recent years. It will grow from $4.1 billion in 2024 to $4.24 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to increased prevalence of helicobacter pylori infection, rising use of nonsteroidal anti-inflammatory drugs (NSAIDs), changing lifestyles and dietary habits, awareness campaigns and educational initiatives, focus on stress management.

The peptic ulcer market size is expected to see steady growth in the next few years. It will grow to $4.91 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to emerging therapies and treatment modalities, increasing geriatric population, integration of precision medicine, preventive measures and health promotion, continued research and clinical trials. Major trends in the forecast period include digital health solutions, advancements in treatment modalities, increasing prevalence of helicobacter pylori infection, integration of diagnostic imaging technologies, increasing use of combination therapies.

The rising incidence of obesity is anticipated to drive the growth of the peptic ulcer market in the future. Obesity is a medical condition marked by an excessive accumulation of body fat, typically defined as having a body mass index (BMI) of 30 or higher. It can arise from a combination of genetic, environmental, and lifestyle factors, including poor dietary habits and insufficient physical activity. Obesity leads to an overproduction of stomach acid, compromises the protective mucosal lining of the stomach, and contributes to the development of peptic ulcers. Additionally, excess weight appears to increase inflammation in the gut, which can further facilitate the emergence of peptic ulcers. For example, in September 2024, the Centers for Disease Control and Prevention, a U.S.-based public health agency, reported that between August 2021 and August 2023, the prevalence of obesity among adults was 40.3%, with rates of 39.2% in men and 41.3% in women. Thus, the increasing prevalence of obesity is driving the expansion of the peptic ulcer market.

The escalating rates of smoking are expected to fuel the peptic ulcer market's growth in the foreseeable future. Smoking, the inhalation of vapors from burning plant-based products such as tobacco or marijuana, is a well-established contributor to peptic ulcer disease. Smoking harms the stomach and duodenal linings, reduces blood supply to the stomach, and increases stomach acid production, elevating the incidence of peptic ulcers. For example, data from Quit Victoria in June 2023 highlighted a threefold increase in current cigarette smoking among 14-17-year-olds over four years, reaching 6.7% in 2022. Consequently, the rising smoking rates serve as a driving factor for the peptic ulcer market.

Companies in the peptic ulcer market are focusing on developing innovative products and solutions, obtaining approval from federal agencies to secure a competitive advantage. The development of drugs is essential for managing and treating peptic ulcers, as it helps with symptom management, healing, preventing complications, and addressing the underlying issues. For example, in April 2023, Akums Drugs and Pharmaceutical Ltd., a pharmaceutical formulations and active pharmaceutical ingredients (APIs) company based in India, launched its new formulation, the Combikit, which combines Amoxicillin, Clarithromycin, and Esomeprazole. This Combikit has been approved by the Central Drugs Standard Control Organisation (CDSCO) for the treatment of duodenal ulcers associated with Helicobacter pylori (H. pylori) and for the eradication of H. pylori in patients with either active or healed peptic ulcers. The therapy targeting H. pylori has shown effectiveness in reducing the risk of ulcer recurrence, providing significant advantages to patients. H. pylori is a common infection in India and is linked to the development of gastritis and peptic ulcers.

In July 2022, Juvise Pharmaceuticals, a France-based pharmaceutical company, acquired the global commercial rights to Pylera from AbbVie Inc. for $408 million (€400 million). Pylera, an antimicrobial tri-therapy, targets peptic ulcers caused by Helicobacter pylori (H. pylori) infection. This acquisition is expected to facilitate Juvise Pharmaceuticals' expansion of its gastro-intestinal medicine product portfolio, serving as a strategic addition for geographic expansion. AbbVie Inc., a U.S.-based pharmaceutical company, specializes in providing various medications for diverse conditions, including peptic ulcers.

Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the peptic ulcer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The peptic ulcer market consists of revenues earned by entities by providing treatment services related to peptic ulcer such as surgeries, endoscopy, blood tests, and physical exams. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptic ulcer market also includes sales of acid blockers, cytoprotective agents, bismuth subsalicylate, and mastic powder. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peptic Ulcer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peptic ulcer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peptic ulcer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptic ulcer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Indication: Gastritis; Gastric Ulcer; Duodenal Ulcer; Gastroesophageal Reflux Disease (GERD)
• 2) By Drug Type: Proton Pump Inhibitors (PPI); H2 Antagonists; Antibiotics; Other Drugs
• 3) By Distribution Channel: Hospital Pharmacies; Private Clinics; Drug Store; Retail Pharmacies; E-Commerce
• Subsegments:
• 1) By Gastritis: Acute Gastritis; Chronic Gastritis
• 2) By Gastric Ulcer: Acute Gastric Ulcer; Chronic Gastric Ulcer
• 3) By Duodenal Ulcer: Acute Duodenal Ulcer; Chronic Duodenal Ulcer
• 4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD; Erosive GERD
• Companies Mentioned: Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Peptic Ulcer Market Characteristics

3. Peptic Ulcer Market Trends And Strategies

4. Peptic Ulcer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Peptic Ulcer Growth Analysis And Strategic Analysis Framework

• 5.1. Global Peptic Ulcer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Peptic Ulcer Market Growth Rate Analysis
• 5.4. Global Peptic Ulcer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Peptic Ulcer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Peptic Ulcer Total Addressable Market (TAM)

6. Peptic Ulcer Market Segmentation

• 6.1. Global Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gastritis
• Gastric Ulcer
• Duodenal Ulcer
• Gastroesophageal Reflux Disease (GERD)
• 6.2. Global Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proton Pump Inhibitors (PPI)
• H2 Antagonists
• Antibiotics
• Other Drugs
• 6.3. Global Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Private Clinics
• Drug Store
• Retail Pharmacies
• E-Commerce
• 6.4. Global Peptic Ulcer Market, Sub-Segmentation Of Gastritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Gastritis
• Chronic Gastritis
• 6.5. Global Peptic Ulcer Market, Sub-Segmentation Of Gastric Ulcer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Gastric Ulcer
• Chronic Gastric Ulcer
• 6.6. Global Peptic Ulcer Market, Sub-Segmentation Of Duodenal Ulcer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Duodenal Ulcer
• Chronic Duodenal Ulcer
• 6.7. Global Peptic Ulcer Market, Sub-Segmentation Of Gastroesophageal Reflux Disease (GERD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Erosive GERD
• Erosive GERD

7. Peptic Ulcer Market Regional And Country Analysis

• 7.1. Global Peptic Ulcer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Peptic Ulcer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peptic Ulcer Market

• 8.1. Asia-Pacific Peptic Ulcer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peptic Ulcer Market

• 9.1. China Peptic Ulcer Market Overview
• 9.2. China Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peptic Ulcer Market

• 10.1. India Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peptic Ulcer Market

• 11.1. Japan Peptic Ulcer Market Overview
• 11.2. Japan Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peptic Ulcer Market

• 12.1. Australia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peptic Ulcer Market

• 13.1. Indonesia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peptic Ulcer Market

• 14.1. South Korea Peptic Ulcer Market Overview
• 14.2. South Korea Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peptic Ulcer Market

• 15.1. Western Europe Peptic Ulcer Market Overview
• 15.2. Western Europe Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peptic Ulcer Market

• 16.1. UK Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peptic Ulcer Market

• 17.1. Germany Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peptic Ulcer Market

• 18.1. France Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peptic Ulcer Market

• 19.1. Italy Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peptic Ulcer Market

• 20.1. Spain Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peptic Ulcer Market

• 21.1. Eastern Europe Peptic Ulcer Market Overview
• 21.2. Eastern Europe Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peptic Ulcer Market

• 22.1. Russia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peptic Ulcer Market

• 23.1. North America Peptic Ulcer Market Overview
• 23.2. North America Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peptic Ulcer Market

• 24.1. USA Peptic Ulcer Market Overview
• 24.2. USA Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peptic Ulcer Market

• 25.1. Canada Peptic Ulcer Market Overview
• 25.2. Canada Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peptic Ulcer Market

• 26.1. South America Peptic Ulcer Market Overview
• 26.2. South America Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peptic Ulcer Market

• 27.1. Brazil Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peptic Ulcer Market

• 28.1. Middle East Peptic Ulcer Market Overview
• 28.2. Middle East Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peptic Ulcer Market

• 29.1. Africa Peptic Ulcer Market Overview
• 29.2. Africa Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peptic Ulcer Market Competitive Landscape And Company Profiles

• 30.1. Peptic Ulcer Market Competitive Landscape
• 30.2. Peptic Ulcer Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Peptic Ulcer Market Other Major And Innovative Companies

• 31.1. Sanofi S.A
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca plc
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. CSL Limited
• 31.11. Boehringer Ingelheim International GmbH
• 31.12. Eisai Co. Ltd.
• 31.13. Sun Pharmaceutical Industries Ltd.
• 31.14. Otsuka Pharmaceutical Company
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Peptic Ulcer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peptic Ulcer Market

34. Recent Developments In The Peptic Ulcer Market

35. Peptic Ulcer Market High Potential Countries, Segments and Strategies

• 35.1 Peptic Ulcer Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Peptic Ulcer Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Peptic Ulcer Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer